Retroviral-mediated_gene_therapy_for_the_treatment_of_hepatocellular_carcinoma:_an_innovative_approach_for_cancer_therapy._An_approach_involving_retroviral-mediated_gene_therapy_for_the_treatment_of_neoplastic_disease_is_described._This_therapeutic_approach_is_called_"virus-directed_enzyme/prodrug_therapy"_(VDEPT)._The_VDEPT_approach_exploits_the_transcriptional_differences_between_normal_and_neoplastic_cells_to_achieve_selective_killing_of_neoplastic_cells._We_now_describe_development_of_the_VDEPT_approach_for_the_treatment_of_hepatocellular_carcinoma._Replication-defective,_amphotrophic_retroviruses_were_constructed_containing_a_chimeric_varicella-zoster_virus_thymidine_kinase_(VZV_TK)_gene_that_is_transcriptionally_regulated_by_either_the_hepatoma-associated_alpha-fetoprotein_or_liver-associated_albumin_transcriptional_regulatory_sequences._Subsequent_to_retroviral_infection,_expression_of_VZV_TK_was_limited_to_either_alpha-fetoprotein-_or_albumin-positive_cells,_respectively._VZV_TK_metabolically_activated_the_nontoxic_prodrug_6-methoxypurine_arabinonucleoside_(araM),_ultimately_leading_to_the_formation_of_the_cytotoxic_anabolite_adenine_arabinonucleoside_triphosphate_(araATP)._Cells_that_selectively_expressed_VZV_TK_became_selectively_sensitive_to_araM_due_to_the_VZV_TK-dependent_anabolism_of_araM_to_araATP._Hence,_these_retroviral-delivered_chimeric_genes_generated_tissue-specific_expression_of_VZV_TK,_tissue-specific_anabolism_of_araM_to_araATP,_and_tissue-specific_cytotoxicity_due_to_araM_exposure._By_utilizing_such_retroviral_vectors,_araM_was_anabolized_to_araATP_in_hepatoma_cells,_producing_a_selective_cytotoxic_effect.